A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo- controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like Particle Vaccine, in the prevention of oral persisten

Project: Other project

Project Details

StatusActive
Effective start/end date12/12/1912/11/23

Funding

  • Merck Sharp & Dohme Corporation: $8,269.23